Evidence map›Paper›PMID 37440298›Full record

ArticleJMIR human factors2023

Workload, Usability, and Engagement with a Mobile App Supporting Video Observation of Methadone Take-Home Dosing: Usability Study.

Bulat Idrisov, Kevin A Hallgren, Alyssa Michaels, Sean Soth, James Darnton, Paul Grekin, Steve Woolworth, Andrew J Saxon, Judith I Tsui

Open access · goldAbstract read
In one paragraph

Article in JMIR human factors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Bulat IdrisovDepartment of Health Systems and Population Health, University of Washington, Seattle, WA, United States.ORCID https://orcid.org/0000-0002-1971-2572
Kevin A HallgrenDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United States.ORCID https://orcid.org/0000-0001-8386-3984
Alyssa MichaelsDivision of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, United States.ORCID https://orcid.org/0009-0003-4191-4925
Sean SothEvergreen Treatment Services, Seattle, WA, United States.ORCID https://orcid.org/0009-0008-6013-9983
James DarntonEvergreen Treatment Services, Seattle, WA, United States.ORCID https://orcid.org/0000-0002-5850-3757
Paul GrekinDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United States.ORCID https://orcid.org/0000-0001-5134-8371
Steve WoolworthEvergreen Treatment Services, Seattle, WA, United States.ORCID https://orcid.org/0009-0006-5554-631X
Andrew J SaxonDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United States.ORCID https://orcid.org/0000-0003-3880-2589
Judith I TsuiDivision of General Internal Medicine, University of Washington, Seattle, WA, United States.ORCID https://orcid.org/0000-0003-0877-5399
University of Washington · USPerinatal Treatment Services · USUniversity of California, San Francisco · USUniversity of Puget Sound · US

Funding

Developing a tool to assess, provide feedback, and facilitate discussion of mechanisms of change in frontline addiction treatmentK01AA024796 · NIAAA · UNIVERSITY OF WASHINGTON · PI HALLGREN, KEVIN A. · 2016 to 2020
$870k
Feasibility of mHealth technology-enabled service for remote observed therapy of methadone and COVID-19 screening for patients in an opioid treatment programR41DA053081 · NIDA · EMOCHA MOBILE HEALTH, INC. · PI SEIGUER, SEBASTIAN, TSUI, JUDITH · 2020 to 2020
$225k
NIAAA NIH HHS K01 AA024796NIDA NIH HHS R41 DA053081
6 · The paper itself

Abstract

backgroundMethadone, a cornerstone of opioid use disorder treatments for many decades, is an essential tool for combatting the opioid epidemic. However, requirements for observing methadone dosing in person through direct observed therapy (DOT) impose significant barriers for many patients. Digital technology can facilitate remote DOT, which could reduce barriers to methadone treatment. Currently, there are limited data on the usability of such technology among patients and counselors in methadone treatment settings.

objectiveThe primary objective of this study was to assess the workload, usability, and engagement of a video-based DOT mobile app for patients with opioid use disorder receiving methadone treatment. The secondary objective was to assess the workload, usability, and engagement of the provider-facing app portal used by counselors.

methodsPatients (n=12) and counselors (n=3) who previously tried video DOT for methadone through a smartphone app in an opioid treatment program participated in usability testing sessions. Participants completed essential tasks for video DOT, then provided ratings of workload (NASA Task Load Index), usability (modified System Usability Scale), and engagement (modified Engagement Scale) with the core features of the video DOT program.

resultsPatients and counselors reported low mental, physical, and temporal demands, successful performance, low effort, and low frustration associated with activities. Patients reported high usability (mean 85, SD 9.5) and engagement (mean 3.8, SD 1.1); counselors reported moderate usability (mean 43.3, SD 17.7) and engagement (mean 2.81, SD 0.63).

conclusionsA mobile health app that facilitates video-based DOT for methadone required a low workload for patients and counselors and was highly usable for patients in an opioid treatment program; however, there are opportunities to improve usability and engagement for the counselor-facing portal.

Indexed as

addictiondirect observed therapyhealth appmethadonemHealthmobile appmobile healthopioidsmartphone appsubstance useusabilityuser engagementuser testingworkload

Identifiers

PMID37440298
PMCPMC10375394
OpenAlexW4378190822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.